Skymet weather

India launches first ayurvedic anti-diabetic drug

February 4, 2016 3:26 PM |

India launches first ayurvedic anti-diabetic drugMake in India is in full swing as the country continues to perform wonders in the field of medical science. After claiming to have developed the world’s first Zika Vaccine, India has added yet another feather in its cap.

Country’s first ayurvedic anti-diabetic drug has been launched by the Council for Scientific and Industrial Research (CSIR).

The drug has been named as BGR-34 was launched at a function by CSIR’s Senior Principal Scientist Dr. A K S Rawat on February 3, 2016 in Kozhikode, Kerala. Usually, modern anti-diabetes drugs have several side effects, BGR-34 not only controls blood sugar and limiting the adverse effects of other medicinal drugs.

The ayurvedic drug has been successfully developed by CSIR in collaboration with the National Botanical Research Institute and Central Institute for Medicinal and Aromatic Plants. The medicine has been designed for Type 2 Diabetes Mellitus and has been scientifically validated for consumption.

Diabetes, which was once an old man’s disease has now even started affecting people between the age of 30 and 45. India is one of the top countries along with China and the United States. Around 6 crore of the adult Indian population suffers from diabetes. Also, Type 2 Diabetes Mellitus is quite common with hardly any effective solution for it.

Image Credit:

For accurate weather forecast and updates, download Skymet Weather (Android App | iOS App) App.

Other Latest Stories

The advantage of staying at home on a rainy day is that you can get comfortable, turn on your mobile, and get to play at a bitcoin casino with a cup of tea. While that heavy rain is falling, you get to play your favorite bitcoin casino games without any worry in the world. The advantage of playing in a crypto casino is that you can log in anywhere at any time.

latest news

Skymet weather

Download the Skymet App

Our app is available for download so give it a try